CWChristine Watkins

Christine Watkins

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Christine Watkins has a total of 6 co-authors. Here are the top co-authors by number of shared publications:

  • Amandeep Bajwa

    The University of Tennessee Health Science Center

    1 shared publication
  • Canan Kuscu

    Transplant Research Institute, Department of Surgery, University of Tennessee Health Science Center, Memphis, TN 38163, United States

    1 shared publication
  • Cem Kuscu

    Transplant Research Institute, James D. Eason Transplant Institute, Department of Surgery, College of Medicine, The University of Tennessee Health Science Center, Memphis, TN 38163, USA

    1 shared publication
  • Erin Nicole Young

    College of Medicine, University of Tennessee Health Science Center, Memphis, TN, USA

    1 shared publication
  • James D. Eason

    Transplant Research Institute, James D. Eason Transplant Institute, Department of Surgery, College of Medicine, The University of Tennessee Health Science Center, Memphis, TN 38163, USA

    1 shared publication
  • Murat Dogan

    Department of Physiology, Hacettepe University Faculty of Medicine, Ankara, Türkiye ; Department of Surgery, Transplant Research Institute, University of Tennessee Health Science Center, TN, USA

    1 shared publication

Latest Publications

  • Open Access

    A Review of Defatting Strategies for Non-Alcoholic Fatty Liver Disease

    by Erin Nicole Young, Murat Dogan, Christine Watkins, Amandeep Bajwa, James D. Eason, Canan Kuscu, Cem Kuscu

    Non-alcoholic fatty liver disease is a huge cause of chronic liver failure around the world. This condition has become more prevalent as rates of metabolic syndrome, type 2 diabetes, and obesity have also escalated. The unfortunate outcome for many people is liver cirrhosis that warrants transplantation or being unable to receive a transplant since many livers are discarded due to high levels of steatosis. Over the past several years, however, a great deal of work has gone into understanding the pathophysiology of this disease as well as possible treatment options. This review summarizes various defatting strategies including in vitro use of pharmacologic agents, machine perfusion of extracted livers, and genomic approaches targeting specific proteins. The goal of the field is to reduce the number of necessary transplants and expand the pool of organs available for use.